Literature DB >> 18480157

Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts.

Yihui Liu1, Yan Su, Max Wiznitzer, Olga Epifano, Stephan Ladisch.   

Abstract

Recognition of important roles of gangliosides in normal and abnormal cell function has motivated pharmacological modification of cellular ganglioside content. However, constitutive depletion of gangliosides in untransformed human cells has not been reported. In this context, the recent identification of a kindred carrying a point mutation in the GM3 synthase [ST3Gal5, Siat9] gene (Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, Wang H, Wiznitzer M, Gurtz K, Verganelaki A, Pryde A, Patton MA, Dwek RA, Butters TD, Platt FM, Crosby AH. 2004. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet. 36:1225-1229) provided an opportunity to explore this possibility. We established primary cultures of skin fibroblasts of three patients homozygous for this autosomal recessive defect. They exhibited a 93% reduction in ganglioside content (0.8 +/- 0.2 nmol lipid-bound sialic acid per 10(7) cells versus 12.7 +/- 1.3 nmol per 10(7) normal fibroblasts). Importantly, this marked reduction was not compensated by the activation of an alternate pathway of ganglioside synthesis, as occurs in murine GM3 synthase knockout fibroblasts. Cell morphology appeared unaffected, but under stringent conditions EGF-induced proliferation and migration of the mutant fibroblasts were reduced by 80% and 60%, respectively. Probing potential explanations, we found that EGF binding (effective membrane EGF receptor (EGFR) number) was reduced by 52% (to 6.2 +/- 1.9 from 12.8 +/- 2.0 pmol/10(8) normal fibroblasts, P < 0.01), despite normal total EGFR protein. EGFR activation was likewise reduced as was EGF-induced Rho/Rac1 phosphorylation, which is associated with cell migration. We conclude that this GM3 synthase point mutation almost completely depletes human fibroblast cellular gangliosides, dampens membrane EGFR activation, and modulates related critical cell functions such as proliferation and migration. These cells offer a valuable model for the study of ganglioside modulation of cell function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480157     DOI: 10.1093/glycob/cwn039

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  18 in total

1.  The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.

Authors:  Sangeeta Adak; Diana DeAndrade; Linda J Pike
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

3.  NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis.

Authors:  Luigi Anastasia; Nadia Papini; Francesca Colazzo; Giacomo Palazzolo; Cristina Tringali; Loredana Dileo; Marco Piccoli; Erika Conforti; Clementina Sitzia; Eugenio Monti; Maurilio Sampaolesi; Guido Tettamanti; Bruno Venerando
Journal:  J Biol Chem       Date:  2008-10-22       Impact factor: 5.157

Review 4.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 5.  Human genetic disorders of sphingolipid biosynthesis.

Authors:  Leonardo Astudillo; Frédérique Sabourdy; Nicole Therville; Heiko Bode; Bruno Ségui; Nathalie Andrieu-Abadie; Thorsten Hornemann; Thierry Levade
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

6.  Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo.

Authors:  Roger A Kroes; Huan He; Mark R Emmett; Carol L Nilsson; Franklin E Leach; I Jonathan Amster; Alan G Marshall; Joseph R Moskal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

7.  Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.

Authors:  Y Liu; S Yan; A Wondimu; D Bob; M Weiss; K Sliwinski; J Villar; V Notario; M Sutherland; A M Colberg-Poley; S Ladisch
Journal:  Oncogene       Date:  2010-03-22       Impact factor: 9.867

8.  EGF induces rapid reorganization of plasma membrane microdomains.

Authors:  Erik G Hofman; Arjen N Bader; Hans C Gerritsen; Paul Mp van Bergen En Henegouwen
Journal:  Commun Integr Biol       Date:  2009-05

9.  Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance.

Authors:  Pablo Hh Lopez; Susan Aja; Kazuhiro Aoki; Marcus M Seldin; Xia Lei; Gabriele V Ronnett; G William Wong; Ronald L Schnaar
Journal:  Glycobiology       Date:  2016-09-28       Impact factor: 4.313

10.  Tumor gangliosides accelerate murine tumor angiogenesis.

Authors:  Yihui Liu; Assefa Wondimu; Su Yan; Daniel Bobb; Stephan Ladisch
Journal:  Angiogenesis       Date:  2013-10-29       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.